Skip Navigation

Annals of Oncology 2006 17(10):1473; doi:10.1093/annonc/mdl356
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

in this issue

in this issue

The first 10% of the full text of this article appears below.


   Sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer
 
Several studies in patients with advanced colorectal cancer have shown a statistically significant benefit in overall survival (OS) for the combination of irinotecan and 5-fluorouracil (5-FU) over treatment with 5-FU alone, and the combination of oxaliplatin with infusional 5-FU was shown to be superior to irinotecan plus bolus 5-FU. Nevertheless, salvage treatment was not a prospective part of these studies, and the suboptimal . . . [Full Text of this Article]


   Melanoma micrometastases in sentinel nodes
 

   Follicular lymphoma international prognostic index and histological subtype in predicting histological transformation in follicular lymphoma
 

   Cardiac follow-up in bone tumor survivors
 

   Quote
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?